Showing results (381-390 of 450) with videos related to
Sort By:
Pageof 45
Medicine|October 8, 2003
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patientsRicard Cervera, Munther A Khamashta, Josep Font, et al.Autoimmunity Reviews|April 1, 2024
Disease phenotypes in adult patients with suspected undifferentiated autoinflammatory diseases and PFAPA syndrome: Clinical and therapeutic implicationsVerónica Gómez-Caverzaschi, Jordi Yagüe, Gerard Espinosa, et al.Arthritis and Rheumatism|December 14, 2004
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis TrialFrédéric A Houssiau, Carlos Vasconcelos, David D'Cruz, et al.The Journal of Rheumatology|December 17, 2018
Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification CriteriaSindhu R Johnson, Dinesh Khanna, David Daikh, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|April 12, 2023
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) StudyElena Gkrouzman, Rohan Willis, Danieli Andrade, et al.Arthritis and Rheumatism|September 5, 2002
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamideFrédéric A Houssiau, Carlos Vasconcelos, David D'Cruz, et al.Lupus Science & Medicine|October 7, 2025
Prediction model for renal outcomes in Latin American Mestizo patients with pure proliferative lupus nephritisArturo Villalobos Navarro, Marc Xipell, Estefanía Garduño Hernández, et al.Frontiers in Immunology|November 3, 2025
A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registryAlexander Pine, Ayesha Butt, Laura Andreoli, et al.Frontiers in Immunology|June 11, 2026
Correction: Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohortsClaudia Grossi, Caterina Bodio, Suresh Kumar, et al.Journal of Autoimmunity|April 10, 2009
Prevalence of hepatitis C serum antibody in autoimmune diseasesNancy Agmon-Levin, Maya Ram, Ori Barzilai, et al.Pageof 45